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Abstract
Several studies have proposed different genetic markers of susceptibility to develop chronic
Chagas cardiomyopathy (CCC). Many genes may be involved, each one making a small
contribution. For this reason, an appropriate approach for this problematic is to study a large
number of single nucleotide polymorphisms (SNPs) in individuals sharing a genetic back-
ground. Our aim was to analyze two CCR2 and seven CCR5 SNPs and their association to
CCC in Argentina. A case-control study was carried out in 480 T. cruzi seropositive adults
from Argentinean Gran Chaco endemic region (Wichi and Creole) and patients from Buenos
Aires health centres. They were classified according to the Consensus on Chagas-Mazza
Disease as non-demonstrated (non-DC group) or demonstrated (DC group) cardiomyopa-
thy, i.e. asymptomatic or with CCC patients, respectively. Since, after allelic analysis, 2 out
of 9 studied SNPs did not fit Hardy–Weinberg equilibrium in the unaffected non-DC group
from Wichi patients, we analyzed them as a separate population. Only rs1800024T and
rs41469351T in CCR5 gene showed significant differences within non-Wichi population
(Creole + patients from Buenos Aires centres), being the former associated to protection,
and the latter to risk of CCC. No evidence of association was observed between any of the
analyzed CCR2-CCR5 gene polymorphisms and the development of CCC; however, the
HHE haplotype was associated with protection in Wichi population. Our findings support the
hypothesis that CCR2-CCR5 genes and their haplotypes are associated with CCC; how-
ever, depending on the population studied, different associations can be found. Therefore,
the evolutionary context, in which the genes or haplotypes are associated with diseases,
acquires special relevance.
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Author summary
Chagas disease caused by the infection with the protozoan Trypanosoma cruzi is endemic
in Latin America. In Argentina, it is estimated 1.5 million patients have Chagas disease
and 2.2 million people in risk of T. cruzi infection. The endemic area covers the north of
the country where the conditions, such as high levels of poverty and social exclusion and
low population density, mostly rural, favor T. cruzi infection. Most affected people
remains asymptomatic after infection for the rest of their lives, but around one third of
infected people may develop clinical symptoms of visceral damage. Chronic Chagas Car-
diomyopathy (CCC), the most frequent and severe consequence of the chronic infection
by T. cruzi, is manifested predominately as an arrhythmogenic cardiomyopathy. The
pathogenesis of CCC is not completely understood, but it is believed that the human
genetic variation may be a determinant factor of disease progression. We studied in Wichi
and in admixed populations from Argentina the CCR2-CCR5 genes, two CC chemokine
receptors involved in the trafficking of several immune cells and in the pathogenesis of
cardiovascular diseases. Our results showed that CCR2-CCR5 genes are associated with
CCC and highlight the relevance of the evolutionary context in which disease-associated
genes are found.
Introduction
About one third of Trypanosoma cruzi chronically infected people will develop chronic Chagas
cardiomyopathy (CCC). The clinical manifestations of CCC are ventricular arrhythmias, sud-
den cardiac death, chronic heart failure, thromboembolic phenomena and precordial chest
pain [1]. The causes behind CCC development remain unclear; however, host, parasitic and
environmental factors should be taken into account for a better understanding of the disease.
There is clinical manifestations heterogeneity according to the geographical region [2] and
the corresponding circulating T. cruzi genotypes [3]. In this context, several association studies
between parasite strain or lineages and CCC have been carried out with negative results [4, 5].
Regarding host genetic characteristics, genetic markers of CCC susceptibility have been pro-
posed [6]. In particular, research has focused on single nucleotide polymorphisms (SNPs), the
most represented type of polymorphism in the human genome. As immune response and
chronic inflammation are mechanisms involved in CCC, several studies have been focused on
different polymorphisms in chemokines and cytokines genes as genetic markers for suscepti-
bility to develop CCC. They have been carried out in endemic countries such as Peru [7],
Mexico [8, 9], Colombia [10–15], Brazil [16–19] and Bolivia [20]. In Argentina, where approx-
imately one million and a half people are infected (4% of the total population), with a preva-
lence in endemic areas greater than 60% [21], until now only there were association studies for
HLA class II DRB1 alleles with CCC [22, 23], but not for those immunological genes men-
tioned above.
Previously case-control studies conducted in Santander, Colombia, have identified SNPs
significantly associated with CCC severity in CCR2 and CCR5 loci [15, 24], which encode two
CC chemokine receptors involved in the trafficking of leukocytes and in cardiovascular dis-
eases pathogenesis [25]. It is essential to make replication studies of genotype–phenotype asso-
ciations for establishing their direct relationship with the disease [26].
Thus, the aim of this study was to analyse SNPs in CCR2 and CCR5 and their association
with CCC in patients who attend to health centers of Buenos Aires and populations from
endemic area as the Gran Chaco ecoregion, with a high prevalence of infection.
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Methods
Ethics statement
The research protocols followed the tenets of the Declaration of Helsinki and Guidelines
according to Resolution N˚1480/11 of the “Ministerio de Salud” from Argentina and were
approved by the Local Medical Ethics Committees named Committee of The Institute of
Regional Medicine of the Northeastern National University (UNNE), Resistencia, Chaco;
IDACH (Chaco Aboriginal Institute); Committees of Ramos Mejı´a and Pirovano Hospitals
from Buenos Aires, upon written informed consents of adult individuals.
Study populations
A case-control study has been carried out including 480 individuals serologically positive for
T. cruzi antigens inhabiting in endemic zone of the Provinces of Chaco and Formosa, i.e.
Argentinean Gran Chaco Region, and in patients of health centers of Buenos Aires from April
2012 to November 2017. They were classified according to the Consensus on Chagas-Mazza
Disease [27] as individuals with non-demonstrated cardiomyopathy (non-DC group) or with
demonstrated cardiomyopathy (DC-group). The non-DC group, which represents the control
group, were individuals with chronic infection but lacking clinical symptoms: they do not
show obvious pathological signs during the cardiovascular physical examination and the com-
plementary studies performed (electrocardiogram, stress test, etc.) were normal as established
for each practice. The DC-group, which represents the case group, was constituted by seroposi-
tive individuals with clinical symptoms and electrocardiography alterations.
Genotyping
Genomic DNA was isolated from 400 μL of EDTA anticoagulated peripheral blood sample
using the DNA extraction kit (High Pure PCR Template Preparation Kit, Roche) and SNPs
were determined by TaqMan 5´ allelic discrimination assay method performed by Applied
Biosystems. The SNPs studied were: rs1799864 and rs3138042 in CCR2 and rs2856758,
rs2734648, rs1799987, rs1799988, rs41469351, rs1800023 and rs1800024 in CCR5.
Statistical analysis
The control group (non-DC group) was tested for all markers on Hardy–Weinberg equilib-
rium (HWE) and a p-value <0.01 was considered as evidence of deviation from HWE. HWE,
frequencies, odds ratios (OR), their 95% confidence intervals (CIs) and the genetic effect of
each polymorphism in CCC, assessed by logistic regression model with cases or controls (DC
and non-DC groups, respectively) as the dependent variables were calculated using PLINK
V1.07 software [28]. As age and gender are possible confounding variables they were included
as additional covariates in the analysis and p-values were adjusted for multiple testing by Bon-
ferroni. Wright’s fixation coefficient to establish population’s structuring were determined by
the Arlequin 3.11 software [29]. Correspondence analyses were carried out using R statistical
package and pairwise linkage disequilibrium (LD), coefficient of linkage disequilibrium (D´)
and haplotypes were estimated with an expectation–maximization algorithm implemented the
Haploview 4.2 software [30]. The statistical power of our study was calculated with the Genetic
Power Calculator for one-stage case–control studies. (http://zzz.bwh.harvard.edu/gpc/) [31].
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Results
Population characterization
The samples included patients from Buenos Aires health centres and individuals from rural
endemic region localities: Rı´o Muerto, Las Hacheras, Misio´n Nueva Pompeya, Miraflores
(Chaco) and Las Lomitas, Pozo del Tigre, Laguna Yema, Estanislao del Campo (Formosa).
After genotype frequencies analysis in the control group (non-DC), two out of 9 genotyped
loci, rs1799864 and rs1800024, did not fit HWE (p<0.002 and 0.005, respectively) and the Fst
fixation coefficient showed moderate genetic differentiation of the population (Fst = 0.102). As
in the endemic surveyed region co-habit different communities and two of them (Native
American Wichis and Creoles) were included in this study, we decided to divide our popula-
tion in three potential subpopulations: patients from Buenos Aires (n = 202), Native American
Wichis (n = 144) and Creoles (n = 134).
We performed allele frequencies comparison, considering both DC and non-DC groups,
among the three subpopulations (Creole, Wichi and patients from Buenos Aires centres) by
Chi-square test of homogeneity. This test demonstrated that allele frequencies were the same
for Creole and patients from Buenos Aires centres, but they all differ from Wichi subpopula-
tion (p-values<0.05). Fig 1A shows the minor allele frequency (MAF) for the three potential
subpopulations. Moreover, the correspondence analysis also indicated population structure
(Fig 1B), as the first dimension explained 83.39% of the variance. In concordance with the pre-
vious results this analysis showed that genotype frequencies of the Gran Chaco Wichi popula-
tion differ to the Creole population from the same endemic region and also to the Buenos
Aires patients (non-endemic). However, these last two groups (Creoles and patients that lived
Fig 1. (A) Minor allele frequencies for SNPs in CCR2-CCR5 gene region in three subpopulations from Argentina: Patients from Buenos Aires
centres (non-endemic), and two populations from endemic region, Creole and Wichi. (B) Correspondence analysis. Genotypes for each polymorphic
site and populations are represented in a two dimensional plot.
https://doi.org/10.1371/journal.pntd.0007033.g001
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in Buenos Aires), which share a Caucasian genetic background and have similar genotype fre-
quencies, were considered as a same population that was named as “non-Wichi population”
(n = 336). Thus, the subsequent association analyses between non-DC and DC groups were car-
ried out independently in these two subpopulations: non-Wichi and Wichi.
Ages in non-DC and DC groups within non-Wichi or Wichi populations were similar
(p = 0.0642 and 0.249, respectively), while significant differences were observed between popu-
lations (p<0.0001) (Table 1). Regarding to gender, populations were homogeneous samples
(p = 0.08 and 0.2837, non-Wichi or Wichi samples, respectively) (Table 1).
Regarding the clinical characteristics of these populations, Wichi patients presented normal
vital signs, regular pulse, although episodes of dizziness and normal systolic blood pressure or
hypotension were observed. In general, they were asymptomatic patients, and only the pres-
ence of palpitations or dyspnea were found in aborigines over 60 years of age. The EKG
showed a heart rate of less than 60 beats per minute; therefore sinus bradycardia and left ante-
rior hemiblock could be detected. Instead, non-Wichi patients presented paroxysmal palpita-
tions, dyspnea on exertion, paroxysmal nocturnal dyspnea and syncope. A higher prevalence
of chronic decompensated heart failure and dilated cardiomyopathy as well as hypertensive
patients were observed, with systolic blood pressure greater than 140 mmHg and diastolic
blood pressure greater than 90 mmHg. In the EKG, these patients presented ventricular extra-
systoles, with a greater presence of complete right bundle branch block than left anterior hemi-
block and also bifascicular block with ventricular premature beats. These intraventricular
disorders appeared at younger ages compared to aboriginal patients.
Allelic and genotypic association analysis
In non-Wichi population the only SNPs with significant differences (Table 2) in the allelic anal-
ysis were: rs1800024T, p = 0.041; OR = 0.69 (0.49–0.99), with a lower frequency of 0.218 in DC
compared to 0.286 in non-DC group; and rs41469351T with frequencies of 0.038 and 0.008 in
DC and non-DC groups, respectively (p = 0.028; OR = 4.88 (1.03–23.24)) (Table 2). No differ-
ences were observed in genotype frequencies between groups.
No association was found in none of the studied SNPs in allele frequencies within the Wichi
population (Table 2). The association test could only be implemented in rs1799864 and
rs1800024.
Haplotype analysis
To evaluate linkage disequilibrium between pairs of SNPs in CCR2-CCR5 region, an analysis
using Haploview was performed. Both populations showed linkage disequilibrium among
studied SNPs (Fig 2).
Haplotypes were constructed based on the evolution of linked CCR2 and CCR5 mutations,
including only the rs1799864 for CCR2 and the seven CCR5 SNPs, as it was previously defined
Table 1. Characterization of the populations studied.
Variables non-Wichi Wichi
DC non-DC DC non-DC
Age (years) Median [rank] 56 [17–85] 52.5 [17–81] 36 [16–82] 32 [17–81]
Mean ± SD 54.14 ± 12.76 51.30 ± 15.15 38.40 ± 14.72 35.43 ± 14.04
Gender (n) Male (n/%) 93/54.7 75/45.2 26/57.7 47/47.5
Female (n/%) 77/45.3 91/54.8 19/42.2 52/52.5
Total (n) 170 166 45 99
https://doi.org/10.1371/journal.pntd.0007033.t001
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Table 2. Relative genotype and allele frequencies for non-Wichi and Wichi populations.
SNP non-Wichi Wichi
DC
n = 170
non-DC
n = 166
padjusted DC
n = 45
non-DC
n = 99
padjusted
CCR2 rs1799864 AA 0.082 0.062 0.359 0.534 0.394 0.241
AG 0.324 0.395 0.332 0.384
GG 0.594 0.543 0.134 0.222
A 0.244 0.259 0.653 0.7 0.586 0.064
G 0.756 0.741 0.3 0.414
rs3138042 GG 0.077 0.073 0.994 - - NA
GA 0.423 0.423 0.1 0.038
AA 0.5 0.504 0.9 0.962
G 0.288 0.285 0.937 0.05 0.02 0.187
A 0.712 0.715 0.95 0.98
CCR5 rs2856758 GG 0.01 0.008 NA - - NA
GA 0.144 0.179 - 0.064
AA 0.846 0.813 1 0.936
G 0.082 0.098 0.568 - 0.032 0.106
A 0.918 0.902 1 0.968
rs2734648 TT 0.124 0.054 0.083 0.022 - NA
TG 0.412 0.44 0.089 0.051
GG 0.465 0.506 0.888 0.949
T 0.329 0.274 0.128 0.067 0.025 0.089
G 0.671 0.726 0.933 0.975
rs1799987 GG 0.173 0.106 0.319 - - NA
GA 0.423 0.48 0.074 0.064
AA 0.404 0.415 0.926 0.936
G 0.385 0.346 0.398 0.038 0.032 0.827
A 0.615 0.654 0.962 0.968
rs1799988 TT 0.182 0.103 0.096 0.022 - NA
TC 0.412 0.485 0.067 0.092
CC 0.406 0.412 0.911 0.908
T 0.388 0.345 0.251 0.054 0.045 0.712
C 0.612 0.655 0.946 0.955
rs41469351 TT - - NA - - NA
TC 0.077 0.016 - -
CC 0.923 0.984 1 1
T 0.038 0.008 0.028� - - NA
C 0.962 0.992 1 1
rs1800023 GG 0.106 0.048 0.141 0.022 - NA
GA 0.418 0.44 0.089 0.051
AA 0.476 0.512 0.888 0.949
G 0.315 0.268 0.184 0.067 0.025 0.089
A 0.685 0.732 0.933 0.975
rs1800024 TT 0.065 0.078 0.071 0.511 0.414 0.258
TC 0.306 0.416 0.377 0.363
CC 0.629 0.506 0.112 0.222
T 0.218 0.286 0.041� 0.7 0.596 0.09
C 0.782 0.714 0.3 0.404
NA: not applicable
�p < 0.05
https://doi.org/10.1371/journal.pntd.0007033.t002
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for HIV-1 studies association [32]. As the SNP rs3138042 does not take part of the haplotypes
already described by Mummidi et al. [32], it was excluded for this analysis.
HHE and HHC were the most represented haplotypes in non-Wichi population and none
described haplotypes showed significant differences between DC and non-DC groups
(Table 3). Among Wichi, HHF�2 was the most frequent haplotype followed by HHE, with a
higher frequency in non-DC than DC group (p = 0.022; OR = 0.49 (0.29–1.23)) (Table 3).
Discussion
Population genetic structure is the consequence of previous demographic events and gene and
culture co-evolution [33–35], both with different rates and rules. A study in human mummies
Fig 2. LD plot across CCR2-CCR5 region. A high-resolution LD among SNPs studied in non-Wichi (A) and Wichi (B) populations. D´ values are reported in the boxes
and represented such a colour scale from red (higher D´scores) to white colour (lower D´ scores).
https://doi.org/10.1371/journal.pntd.0007033.g002
Table 3. Haplogroup frequencies.
Haplotype a1 3 4 5 6 7 8 9 non-Wichi Frequencies Wichi Frequencies
Total DC. non-DC p Total DC. non-DC p
HHA G A G G T C A C 0.056 0.049. 0.063 0.41 0.014 0.011. 0.016 0.768
HHB G A T G T C A C 0.004 0.001. 0.008 0.16 0 0 -
HHC G A T G T C G C 0.24 0.260. 0.219 0.214 0.024 0.044. 0.015 0.144
HHD G A T G T T A C 0.014 0.015. 0.013 0.819 0 0 -
HHE G A G A C C A C 0.278 0.278. 0.279 0.965 0.236 0.151. 0.275 0.022�
HHF�1 G A G A C C A T 0.031 0.028. 0.034 0.674 0.076 0.082. 0.073 0.786
HHF�2 A A G A C C A T 0.189 0.167. 0.213 0.131 0.543 0.595. 0.520 0.236
HHG G G G A C C A C 0.077 0.067. 0.086 0.365 0.015 0.000. 0.022 0.152
a) 1 = rs1799864; 3 = rs2856758; 4 = rs2734648; 5 = rs1799987; 6 = rs1799988; 7 = rs41469351; 8 = rs1800023; 9 = rs1800024
Grey boxes denote a base change in the haplogroup respect to the ancestral HHA haplotype.
�p < 0.05
https://doi.org/10.1371/journal.pntd.0007033.t003
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showed that T. cruzi transmission among infected wild reservoirs was probably established in
the first moment of Andean coast human colonization [36], suggesting that T. cruzi and
humans co-evolved from over 9000 years and thus, south Amerindians may have developed a
peculiar way of dealing with T. cruzi infection [37]. Thus, host-pathogen interaction is another
factor to be taken into account for understanding population genetic evolution.
Wichi is one of the Argentinian native populations, with its own cultural patterns, that
inhabit the Impenetrable Chaqueño, a region with extreme climatic conditions and scarce
urban centres communication. This isolation results in a genetic differentiation from other
populations [37, 38]. In concordance with this data, our results in some T. cruzi seropositive
Argentinian populations showed that the Wichi community exhibits different allele frequen-
cies compared to the Impenetrable Chaqueño Creole population which is genetically similar to
patients from Buenos Aires centres (admixed populations) in the studied locus. Moreover, the
correspondence analysis indicated a clear genotype frequencies differentiation between Wichi
and the other sub-populations: in Wichi 4 out of 9 SNPs showed allele frequencies close to
zero and for the two SNPs located at both extremes of the gene region studied (rs1799864 and
rs1800024) the most represented alleles were not the ancestral. These results reinforced the
subdivision in Wichi and non-Wichi groups for genetic analysis and highlight the importance
of studying the different genetic backgrounds of Amerindian populations. Despite limitations
related to both Wichi and non-Wichi sample sizes and since the prevalence of Chagas disease
in endemic areas is greater than 60% [39], statistical power calculation of our study showed
that subdivision in two groups have a power of 80% (S1 Table).
Chemokines have been associated not only with the initial control of T. cruzi infection, but
also the maintenance of chronic inflammation resulting from the inability of immune system
to eliminate the parasite [40]. In different studies, common CCR5 SNPs were analysed individ-
ually with variable results. In Colombian population was found that rs2856758G, within the
CCR5 promoter region, was associated with a reduced risk of susceptibility to develop CCC
[24]. In our populations this allele has a very low frequency compared to that observed among
Colombians, suggesting a possible reason why the association is not replicated. In this work,
like in Flo´rez et al. [24], we found no evidence of association of both rs1799987 and rs1799988
variants which had been previously described in Peruvian and Venezuelan [41, 42]. This dis-
crepancy might be the result of lower size sample in the last reports (less than a hundred
patients), with a higher probability of positive false.
Our results also showed a significant rs1800024T decreased frequency in non-Wichi popu-
lation DC group suggesting protection to CCC, while Machuca et al. [15] observed in Colom-
bians that it correlated with CCC severity. Rs1800024T is the allele that characterizes the HHF
haplotype (HHF�1 and HHF�2) which is associated with higher levels of CCR5 expression [32]
as a consequence of a differential binding of T and G alleles to certain nuclear factors, espe-
cially factors of the NFkB family. Likewise, in-silico studies predict that the T allele, together
with other transcription factors such as IRF1 receptors, are involved in the expression of innate
immunity proteins which are important in parasite control and therefore less inflammation
related [32]. Taken together, these results could indicate that higher levels of CCR5 expression
might protect from cardiomyopathy development by decreasing the parasitic load or allowing
parasite control. Meanwhile in those individuals for whom this protection is insufficient, the
parasite and antigenic persistence would stimulate a chronic inflammation responsible for
more severe tissue damage. Something similar could happen in the case of rs2734648T which
binds to nuclear factors with more avidity than the G allele [32] and this might also alter CCR5
protein expression levels. Here we found in the case of non-Wichi population an association
between this SNP and CCC in subjects with 2 copies of this allele (rs2734648TT genotype,
recessive model, p = 0.026) while in Colombians it was associated with less severity [24].
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Regarding the rs41469351T, its frequency was very low both in Colombian and Argentinian
non-Wichi populations, and null among Wichis. In the non-Wichi population we found a
higher frequency of this allele in the DC group, although this significance might be taken care-
fully because of the low frequency values.
Previous studies have shown that several polymorphic changes in the CCR5 promoter, that
define the haplotypes, may influence differently both expression levels of CCR5 surface and pro-
portions of peripheral blood cells expressing this protein [32]. In our study, the HHE haplotype
was the most common haplotype in non-Wichi population followed by HHC and HHF�2. These
three haplogroups were also the most frequent in Colombian population [15, 24], although
none of them were associated with CCC in non-Wichi group. In contrast, in Wichi individuals
only the frequencies of two haplotypes were higher than 0.1, being HHF�2 haplotype the highest
frequent followed by HHE, the latter associated with protection from CCC. Interestingly, the
HHC frequency -one of the most frequent haplotypes in other populations- is considerably low
among Wichis. This haplogroup together with HHA have been associated with a decreased pro-
moter activity, while HHE and HHF are characterized by a higher activity. Therefore, a higher
expression level of CCR5 and CCR2 could favour a greater control of infection with T. cruzi and
thus would be less susceptible to develop CCC. These findings, together with the absence of
rs41469351T, could be some factors involved in a lower prevalence of right bundle branch
block, one of the anomalies mostly observed in the electrocardiograms of CCC patients,
reported in Wichi ethnicity compared to Creole (1.8% vs 10%, respectively, OR = 6.0) [39].
It is important to note that both in the Wichi and in the non-Wichi populations it is possible to
find individuals who manifest the disease at very young ages (Table 1). That is, the clinical onset
seems to be independent of the genetic background, but risk of susceptibility to developing CCC
would not be. Although our study presents some limitations in sample size our results are valuable
as they described a unique population with a large history of co-evolution with the parasite.
In summary, our findings support the hypothesis that CCR2-CCR5 genes and their haplo-
types are associated with CCC and this study also highlight the importance of considering the
evolutionary context in which disease-associated genes or haplotypes are found and to under-
line the possible impact of allele–allele interactions, especially among alleles with different evo-
lutionary histories.
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